Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
European Urology Oncology|May 13, 2026
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled TrialsWei Shen Tan, Ashish M Kamat, Rebecca Lewis, et al.
The Journal of Urology|April 28, 2018
Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?Wei Shen Tan, Rachael Sarpong, Pramit Khetrapal, et al.
European Urology Focus|August 26, 2023
The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines OfficeWout Devlies, Joep J de Jong, Fabian Hofmann, et al.
European Urology|September 25, 2020
Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per CapitaJeremy Yuen-Chun Teoh, Junjie Huang, Wendy Yuet-Kiu Ko, et al.
European Urology|April 15, 2018
Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 PatientsWei Shen Tan, Andrew Feber, Rachael Sarpong, et al.
European Urology|April 8, 2022
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with HaematuriaBhavan P Rai, José Luis Dominguez Escrig, Luís Vale, et al.
BJU International|January 21, 2023
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019James W F Catto, Olena Mandrik, Lewis A Quayle, et al.
European Urology|October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)John D Kelly, Wei Shen Tan, Nuria Porta, et al.
European Urology Focus|November 25, 2018
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology|August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialWei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
Pageof 7